ASSESSMENT OF THE EFFECTIVENESS OF NEUROPROTECTIVE THERAPY IN THE EARLY REHABILITATION OF PATIENTS AFTER ISCHEMIC STROKE

Ischemic stroke remains one of the leading causes of mortality and long-term disability worldwide. It is associated with profound socioeconomic consequences for both patients and healthcare systems. With the aging population and increasing prevalence of risk factors such as hypertension, diabetes mellitus, and atrial fibrillation, the incidence of ischemic stroke is steadily rising. While substantial advancements have been made in the acute management of stroke through thrombolysis and thrombectomy, the early rehabilitation phase remains a crucial yet often underutilized period for optimizing neurological recovery. This period, characterized by heightened neuroplasticity, offers a unique window during which targeted interventions can enhance neuronal repair and functional restoration. Among such interventions, neuroprotective therapy has garnered growing attention due to its ability to mitigate secondary brain injury and support neural regeneration.